Histone Deacetylases Contribute to Excitotoxicity-Triggered Degeneration of Retinal Ganglion Cells In Vivo
- 3 June 2019
- journal article
- research article
- Published by Springer Nature in Molecular Neurobiology
- Vol. 56 (12) , 8018-8034
Abstract
Excitotoxicity is known to modulate the nuclear accumulation, and thus activity state, of histone deacetylases (HDACs) in pyramidal neurons. In the retina, deregulation in activity and expression of different HDACs has been linked to pathological conditions such as retinitis pigmentosa, retinal ischemia, glaucoma, and acute optic nerve injury. Up to now, however, the effects of in vivo excitotoxicity on the different HDACs in retinal ganglion cells (RGCs) have not been thoroughly investigated. Here, we injected adult mice intravitreally with N-methyl-D-aspartate (NMDA) as a mean to trigger excitotoxicity-mediated RGC degeneration and we detected time-dependent loss of RGCs at 1 and 7 days after the insult. Further, we characterized the subcellular localization of HDACs belonging to class I (HDAC1, HDAC3), IIa (HDAC4, HDAC5, HDAC7, HDAC9), IIb (HDAC6, HDAC10), and IV (HDAC11) in RGCs. Our analyses revealed a differential pattern of HDACs nuclear distribution in RGCs following excitotoxicity. After 1 day, HDAC3, HDAC5, HDAC6, HDAC7, and HDAC11 showed altered subcellular localization in RGCs while 7 days after the excitotoxic insult, HDAC4 and HDAC9 were the only HDACs displaying changes in their subcellular distribution. Moreover, we found that in vivo selective inhibition of HDAC1/3 or HDAC4/5 via MS-275 (entinostat) or LMK-235, respectively, could prevent ongoing RGC degeneration. In conclusion, our results point towards a role of HDACs in RGC degeneration and identify HDAC1/3 and HDAC4/5 as potential therapeutic targets to treat degenerative retinal diseases.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (FOR2325 project 2, SFB1158 Project A08)
- Universität Heidelberg (FRONTIER)
- PRIN 2016 (20152TE5PK)
- AIRC 2016 (19162)
This publication has 78 references indexed in Scilit:
- Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer's diseaseEMBO Molecular Medicine, 2012
- Nuclear accumulation of HDAC4 in ATM deficiency promotes neurodegeneration in ataxia telangiectasiaNature Medicine, 2012
- Histone Deacetylase 6 (HDAC6) Deacetylates Survivin for Its Nuclear Export in Breast CancerJournal of Biological Chemistry, 2012
- A role for epigenetic changes in the development of retinal neurodegenerative conditionsJournal of Ocular Biology, Diseases, and Informatics, 2011
- Regulation of chromatin by histone modificationsCell Research, 2011
- Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disordersNature Reviews Neuroscience, 2010
- Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin AJournal of the American Chemical Society, 2010
- Inhibition of Histone Deacetylase Protects the Retina from Ischemic InjuryInvestigative Ophthalmology & Visual Science, 2010
- HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damageNature Neuroscience, 2009
- The many roles of histone deacetylases in development and physiology: implications for disease and therapyNature Reviews Genetics, 2009